Port Macquarie Base Hospital

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D. Davis, Andrew Martin, Martin R. Stockler et al. · New England Journal of Medicine · 2019 · 1.5K citations

Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology

Helen Bedford, Katie Attwell, Margie Danchin et al. · Vaccine · 2017 · 327 citations

Vaccination, Preventive Medicine, Medicine +4

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

Werner Scheithauer, J McKendrick, S. Begbie et al. · Annals of Oncology · 2003 · 272 citations · Full text

Gastrointestinal Oncology, Oral Capecitabine, Medicine +8

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer

Salma K. Jabbour, Ki Hyeong Lee, Nikolaj Frost et al. · JAMA Oncology · 2021 · 231 citations · Full text

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

John C. Araujo, Géralyn C. Trudel, Fred Saad et al. · The Lancet Oncology · 2013 · 229 citations · Full text

Double-blind Phase 3, Urology, Genitourinary Cancer +6